Patient Navigation

The noninvasive multitarget stool DNA (mt-sDNA) test includes a nationwide patient navigation program and customer support services to facilitate screening completion. The program provides tracking for healthcare providers so they can measure and monitor patient adherence to Cologuard® screening.

The mt-sDNA testing program provides a 24/7 patient and provider navigation system with interpreter services in over 240 languages1

The program includes patient reminders to aid test completion1

This program also provides tracking for healthcare providers so they can measure and monitor patient adherence to Cologuard® screening1

PATIENT NAVIGATION PROGRAM1-6

The mt-sDNA Test Includes a Built-In Patient Navigation Program With 24/7 Patient Support for Questions, Reminders, and Calls to Support Completion of the Test1,2

System barrier:

Lack of reminder systems can contribute to less-than-optimal screening3

The figure demonstrates the flow of the patient navigation program, from collection kit shipment to patients to results delivery. The general flow of this graphic starts with the laboratory shipping the collection kit to the patient, then moves to the patient properly storing the kit until use, then the patient navigation program will reach out to the patient in a variety of ways to remind them to complete the test, then the patient will ship the completed test back to the laboratory. From there, the laboratory will process the test and send the results to the patient’s healthcare provider, who will relay the result to the patient. If the result is positive, the next step is a colonoscopy referral. If the text is negative, the patient will receive continued screening at appropriate intervals.

Learn more about the full Indications/Contraindications for the mt-sDNA test. Please see complete prescribing information for the Cologuard® test in the Cologuard Clinician Brochure.

FIT: fecal immunochemical test; mt-sDNA: multitarget stool DNA.

Related Topics

Footnotes

  1. Per ACS guidelines.6

List of definitions

mt-sDNA: multitarget stool DNA.


References

  1. Cologuard Clinician Brochure. Exact Sciences Corporation. Madison, WI.
  2. Cologuard Patient Guide. Exact Sciences Corporation. Madison, WI.
  3. Wang H, Gregg A, Qiu F, et al. Provider Perceived Colorectal Cancer Screening Barriers: Results from a Survey in Accountable Care Organizations. JOJ Public Health. 2017;1(2):555557.
  4. Weiser E, Parks PD, Swartz RK, et al. Cross-sectional adherence with the multi-target stool DNA test for colorectal cancer screening: Real-world data from a large cohort of older adults. J Med Screen. 2021;28(1):18-24.
  5. Anand S, Liang PS. A Practical Overview of the Stool DNA Test for Colorectal Cancer Screening. Clin Transl Gastroenterol. 2022;13(4):e00464.
  6. Wolf AMD, Fontham ETH, Church TR, et al. Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society. CA Cancer J Clin. 2018;68(4):250-281.